Irinotecan Labatec 40 mg/2 ml, solution à diluer pour perfusion
7680592840012
CH-59284
Lösung
Associated product:
IRINOTECAN Labatec 40 mg/2ml flac 2 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
90.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 57.60
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2010
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59284
- Drug name
- Irinotecan Labatec, solution à diluer pour perfusion
- Galenic form
- KOPA
- ATC Code
- L01XX19
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 04/12/2009
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- IRINOTECAN Labatec 40 mg/2ml flac 2 ml
- Description (DE)
- IRINOTECAN Labatec 40 mg/2ml Durchstf 2 ml
- Market launch
- 04/12/2009
- Narcotic (BTM)
- No